Literature DB >> 34596718

The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction.

Mitchell Davis1, Mohammad Reza Movahed1,2, Mehrtash Hashemzadeh1, Mehrnoosh Hashemzadeh3,4.   

Abstract

Platelets play an integral role in the pathogenesis of acute coronary syndrome (ACS). The purpose of this study was to investigate any correlation between immune thrombocytopenia (ITP) and non-ST segment elevation myocardial infarction (NTSEMI), a common presentation of ACS. Using the large Nationwide Inpatient Sample (NIS) database, we studied any correlation between NSTEMI and ITP utilizing ICD-9 codes. We performed uni- and multivariate analysis adjusting for risk factors from the years 2002-2011. Data was extracted from 106,653 ITP patients and 79,636,090 controls. In multiple years of the study period (2002-2011), NSTEMI incidence was significantly higher in ITP patients when compared with non-ITP patients in the univariate analysis (odds ratio average 1.226). However, no significant association was found after adjusting for additional risk factors in multivariate analysis. Based on our large database study, ITP is not independently associated with NSTEMI incidence after adjusting for comorbidity.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Acute coronary syndrome; Autoimmune thrombocytopenia; Bleeding; ITP; Idiopathic thrombocytopenic purpura; Myocardial infarction; Thrombocytopenic; Type 2 myocardial infarction

Mesh:

Year:  2021        PMID: 34596718     DOI: 10.1007/s00277-021-04668-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  28 in total

Review 1.  Platelet activation and atherothrombosis.

Authors:  Giovanni Davì; Carlo Patrono
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

Review 2.  Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention.

Authors:  Antonio Russo; Marina Cannizzo; Gabriele Ghetti; Elena Barbaresi; Elisa Filippini; Salvatore Specchia; Angelo Branzi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-05-16

3.  Role of platelets in cholesteryl ester formation by U-937 cells.

Authors:  M E Mendelsohn; J Loscalzo
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study.

Authors:  J S Chandan; T Thomas; S Lee; T Marshall; B Willis; K Nirantharakumar; P Gill
Journal:  J Thromb Haemost       Date:  2018-02-05       Impact factor: 5.824

5.  Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody.

Authors:  T Yasuda; H K Gold; R C Leinbach; T Saito; J L Guerrero; I K Jang; R Holt; J T Fallon; D Collen
Journal:  J Am Coll Cardiol       Date:  1990-12       Impact factor: 24.094

6.  Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.

Authors:  J F Eidt; P Allison; S Noble; J Ashton; P Golino; J McNatt; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  Phagocytized platelets: a source of lipids in human thrombi and atherosclerotic plaques.

Authors:  A B CHANDLER; R A HAND
Journal:  Science       Date:  1961-09-29       Impact factor: 47.728

8.  Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.

Authors:  T Yasuda; H K Gold; J T Fallon; R C Leinbach; J L Guerrero; L E Scudder; M Kanke; D Shealy; M J Ross; D Collen; B S Coller
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

9.  Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart.

Authors:  J K Mickelson; P J Simpson; B R Lucchesi
Journal:  J Mol Cell Cardiol       Date:  1989-04       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.